https://scholars.lib.ntu.edu.tw/handle/123456789/596499
標題: | High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection | 作者: | JYH-CHIN YANG CHUN-JUNG LIN Wang H.-L. Chen J.-D. Kao J.Y. CHIA-TUNG SHUN Lu C.-W. BOR-RU LIN MING-JIUM SHIEH MING-CHU CHANG YU-TING CHANG SHU-CHEN WEI Lin L.-C. Yeh W.-C. Kuo J.-S. CHIEN-CHIH TUNG Leong Y.-L. Wang T.-H. Wong J.-M. |
公開日期: | 2015 | 出版社: | W.B. Saunders | 卷: | 13 | 期: | 5 | 起(迄)頁: | 895-905.e5 | 來源出版物: | Clinical Gastroenterology and Hepatology | 摘要: | The efficacy of treatment of Helicobacter pylori infection has decreased steadily because of increasing resistance to clarithromycin, metronidazole, and levofloxacin. Resistance to amoxicillin is generally low, and high intragastric pH increases the efficacy of amoxicillin, so we investigated whether a combination of a high-dose proton pump inhibitor and amoxicillin (dual therapy) was more effective than standard first-line or rescue therapies in eradicating H pylori. ? 2015 AGA Institute. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927911344&doi=10.1016%2fj.cgh.2014.10.036&partnerID=40&md5=c1a08f6e844bb1bf05e86b8a6bbf4673 https://scholars.lib.ntu.edu.tw/handle/123456789/596499 |
ISSN: | 1542-3565 | DOI: | 10.1016/j.cgh.2014.10.036 | SDG/關鍵字: | amoxicillin; clarithromycin; levofloxacin; metronidazole; proton pump inhibitor; rabeprazole; urea c 13; antiinfective agent; proton pump inhibitor; abdominal disease; abdominal distress; adult; antibiotic resistance; Article; bacterial clearance; controlled study; cytochrome P450 2C19 gene; diarrhea; dizziness; drug efficacy; drug megadose; drug tolerability; drug treatment failure; dysgeusia; female; gene; genotype; Helicobacter infection; human; human tissue; intention to treat analysis; major clinical study; male; nausea; patient compliance; pruritus; randomized controlled trial; treatment outcome; unspecified side effect; adverse effects; aged; clinical trial; combination drug therapy; comparative study; drug effects; Helicobacter Infections; Helicobacter pylori; middle aged; multicenter study; procedures; prospective study; Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。